Physicians remain wary of the wellness trend ...

In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first line of therapy did not improve overall survival (OS) ...

USD 11.58 billion; 2031 Projected Market Size: USD 16.39 billion; CAGR (2026–2031): 7.2%; Chemiluminescence Immun ...

According to MarketsandMarkets, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion in 2026 to USD 16.39 ...

The FDA granted full approval encorafenib (Braftovi) in combination with cetuximab (Erbitux) and fluorouracil-based ...

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

Dr. Kasey Holland Hamski, ND A case illustrating the interplay between EBV reactivation, environmental mold exposure, and immune dysregulation in a patient ...

Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral ...

Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...

XCMG Excavator presented ten excavator models at CONEXPO 2026, one of the world's largest construction equipment trade shows that opened on March 3, highlighting machines and construction solutions ...

Whatfix, the global AI-native platform for enterprise technology adoption, officially launches AI Roleplay training in Mirror, making Mirror an AI-first training platform designed to prepare ...